Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 557

1.

Excisional haemorrhoidectomy: is it safe in patients with an ileal pouch-anal anastomosis?

Lightner AL, Kearney D, Giugliano D, Hull T, Holubar S, Shawki S, Steele SR.

Colorectal Dis. 2020 Jan 31. doi: 10.1111/codi.14996. [Epub ahead of print]

PMID:
32003920
2.

Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials With Meta-Analysis.

Bellastella G, Maiorino MI, Longo M, Scappaticcio L, Chiodini P, Esposito K, Giugliano D.

Stroke. 2020 Feb;51(2):666-669. doi: 10.1161/STROKEAHA.119.027557. Epub 2019 Dec 9.

PMID:
31813360
3.

Beyond basal-bolus insulin regimen: Is it still the ultimate chance for therapy in diabetes?

Giugliano D, Bellastella G, Maiorino MI, Esposito K.

Diabetes Res Clin Pract. 2019 Nov;157:107922. doi: 10.1016/j.diabres.2019.107922. Epub 2019 Nov 9. No abstract available.

PMID:
31715201
4.

Other Surgeries in Patients with Inflammatory Bowel Disease.

Giugliano DN, Bernier GV, Johnson EK.

Surg Clin North Am. 2019 Dec;99(6):1163-1176. doi: 10.1016/j.suc.2019.08.013. Epub 2019 Sep 17. Review.

PMID:
31676055
5.

Excisional Hemorrhoidectomy: Safe in Patients With Crohn's Disease?

Lightner AL, Kearney D, Giugliano D, Hull T, Holubar SD, Koh S, Zaghiyan K, Fleshner PR.

Inflamm Bowel Dis. 2019 Oct 21. pii: izz255. doi: 10.1093/ibd/izz255. [Epub ahead of print]

PMID:
31633186
6.

Measuring the Quality of Diabetes Care.

Giugliano D, Maiorino MI, Esposito K.

JAMA. 2019 Sep 24;322(12):1212. doi: 10.1001/jama.2019.11136. No abstract available.

PMID:
31550021
7.

Primary versus secondary cardiorenal prevention in type 2 diabetes: Which newer anti-hyperglycaemic drug matters?

Giugliano D, Ceriello A, De Nicola L, Perrone-Filardi P, Cosentino F, Esposito K.

Diabetes Obes Metab. 2020 Feb;22(2):149-157. doi: 10.1111/dom.13881. Epub 2019 Oct 17. Review.

PMID:
31495989
8.

GLP-1 receptor agonists for prevention of cardiorenal outcomes in type 2 diabetes: An updated meta-analysis including the REWIND and PIONEER 6 trials.

Giugliano D, Maiorino MI, Bellastella G, Longo M, Chiodini P, Esposito K.

Diabetes Obes Metab. 2019 Nov;21(11):2576-2580. doi: 10.1111/dom.13847. Epub 2019 Aug 28.

PMID:
31373167
9.

Class effect for SGLT-2 inhibitors: a tale of 9 drugs.

Giugliano D, Esposito K.

Cardiovasc Diabetol. 2019 Jul 23;18(1):94. doi: 10.1186/s12933-019-0899-9.

10.

Metabolic effectiveness of gliflozins and gliptins in the routine clinical practice of patients with type 2 diabetes: preliminary results from GIOIA, a prospective multicentre study.

Esposito K, Longo M, Maiorino MI, Petrizzo M, Gicchino M, Bellastella G, Giugliano D.

Diabetes Res Clin Pract. 2019 Sep;155:107787. doi: 10.1016/j.diabres.2019.107787. Epub 2019 Jul 19.

PMID:
31326454
11.

From pump to sink: The hydraulic connection of type 2 diabetes.

Giugliano D, Esposito K, Ceriello A.

Diabetes Res Clin Pract. 2020 Jan;159:107772. doi: 10.1016/j.diabres.2019.06.013. Epub 2019 Jun 28. No abstract available.

PMID:
31260714
12.

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials.

Maiorino MI, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Giugliano D, Esposito K.

Diabetes Res Clin Pract. 2019 Aug;154:101-115. doi: 10.1016/j.diabres.2019.06.009. Epub 2019 Jun 22.

PMID:
31238059
13.
14.

Type 2 diabetes and risk of heart failure: a systematic review and meta-analysis from cardiovascular outcome trials.

Giugliano D, Maiorino MI, Longo M, Bellastella G, Chiodini P, Esposito K.

Endocrine. 2019 Jul;65(1):15-24. doi: 10.1007/s12020-019-01931-y. Epub 2019 Apr 26.

PMID:
31028667
15.

Type 2 diabetes and the kidney: Insights from cardiovascular outcome trials.

Giugliano D, De Nicola L, Maiorino MI, Bellastella G, Esposito K.

Diabetes Obes Metab. 2019 Aug;21(8):1790-1800. doi: 10.1111/dom.13743. Epub 2019 May 2. Review.

PMID:
30969018
16.

EMPATHY: A New Tool for Identifying the Most Suitable Thyroxine Formulation in Hypothyroid Patients.

Bellastella G, Caputo M, Maiorino MI, Longo M, Scappaticcio L, Giugliano D, Esposito K.

Thyroid. 2019 Jul;29(7):928-933. doi: 10.1089/thy.2018.0493. Epub 2019 May 21.

PMID:
30963820
17.

Are gliflozins the new statins for diabetes?

Giugliano D, Maiorino MI, Longo M, Esposito K.

Diabetes Res Clin Pract. 2019 Jul;153:191-193. doi: 10.1016/j.diabres.2019.04.014. Epub 2019 Apr 5. No abstract available.

PMID:
30959149
18.

Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysis.

Giugliano D, Chiodini P, Maiorino MI, Bellastella G, Esposito K.

J Endocrinol Invest. 2019 Oct;42(10):1165-1169. doi: 10.1007/s40618-019-01047-0. Epub 2019 Apr 6.

PMID:
30955180
19.

Diabetes and Aging: From Treatment Goals to Pharmacologic Therapy.

Longo M, Bellastella G, Maiorino MI, Meier JJ, Esposito K, Giugliano D.

Front Endocrinol (Lausanne). 2019 Feb 18;10:45. doi: 10.3389/fendo.2019.00045. eCollection 2019. Review.

20.

Patients with Non-response to Neoadjuvant Chemoradiation for Esophageal Cancer Have No Survival Advantage over Patients Undergoing Primary Esophagectomy.

Chevrollier GS, Giugliano DN, Palazzo F, Keith SW, Rosato EL, Evans Iii NR, Berger AC.

J Gastrointest Surg. 2020 Feb;24(2):288-298. doi: 10.1007/s11605-019-04161-9. Epub 2019 Feb 26.

PMID:
30809782
21.

Heart failure and type 2 diabetes: From cardiovascular outcome trials, with hope.

Giugliano D, Meier JJ, Esposito K.

Diabetes Obes Metab. 2019 May;21(5):1081-1087. doi: 10.1111/dom.13629. Epub 2019 Feb 14. Review.

PMID:
30609236
22.

Clinical inertia, reverse clinical inertia, and medication non-adherence in type 2 diabetes.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

J Endocrinol Invest. 2019 May;42(5):495-503. doi: 10.1007/s40618-018-0951-8. Epub 2018 Oct 6. Review.

PMID:
30291589
23.

Metabolic syndrome and cancer: "The common soil hypothesis".

Bellastella G, Scappaticcio L, Esposito K, Giugliano D, Maiorino MI.

Diabetes Res Clin Pract. 2018 Sep;143:389-397. doi: 10.1016/j.diabres.2018.05.024. Epub 2018 May 26. Review.

PMID:
29807099
24.

Influence of occlusal characteristics, food intake and oral hygiene habits on dental caries in adolescents: a cross-sectional study.

Giugliano D, d'Apuzzo F, Majorana A, Campus G, Nucci F, Flores-Mir C, Perillo L.

Eur J Paediatr Dent. 2018 Jun;19(2):95-100. doi: 10.23804/ejpd.2018.19.02.02.

25.

Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: A systematic review and meta-analysis of randomized controlled trials.

Maiorino MI, Chiodini P, Bellastella G, Scappaticcio L, Longo M, Esposito K, Giugliano D.

Diabetes Obes Metab. 2018 Sep;20(9):2309-2313. doi: 10.1111/dom.13343. Epub 2018 May 24.

PMID:
29732679
26.

Dissonance among treatment algorithms for hyperglycemia in type 2 diabetes: an egalitarian dialog.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

J Endocrinol Invest. 2019 Feb;42(2):237-242. doi: 10.1007/s40618-018-0893-1. Epub 2018 Apr 27. Review. No abstract available.

PMID:
29704235
27.

More sugar? No, thank you! The elusive nature of low carbohydrate diets.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

Endocrine. 2018 Sep;61(3):383-387. doi: 10.1007/s12020-018-1580-x. Epub 2018 Mar 19. Review.

PMID:
29556949
28.

From inflammation to sexual dysfunctions: a journey through diabetes, obesity, and metabolic syndrome.

Maiorino MI, Bellastella G, Giugliano D, Esposito K.

J Endocrinol Invest. 2018 Nov;41(11):1249-1258. doi: 10.1007/s40618-018-0872-6. Epub 2018 Mar 16. Review.

PMID:
29549630
29.

Gender-differences in glycemic control and diabetes related factors in young adults with type 1 diabetes: results from the METRO study.

Maiorino MI, Bellastella G, Casciano O, Petrizzo M, Gicchino M, Caputo M, Sarnataro A, Giugliano D, Esposito K.

Endocrine. 2018 Aug;61(2):240-247. doi: 10.1007/s12020-018-1549-9. Epub 2018 Feb 17.

PMID:
29455365
30.

Comment on Edelman and Polonsky. Type 2 Diabetes in the Real World: The Elusive Nature of Glycemic Control. Diabetes Care 2017;40:1425-1432.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

Diabetes Care. 2018 Feb;41(2):e17. doi: 10.2337/dc17-1826. No abstract available.

PMID:
29358471
31.

Glycemic control in type 2 diabetes: from medication nonadherence to residual vascular risk.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

Endocrine. 2018 Jul;61(1):23-27. doi: 10.1007/s12020-017-1517-9. Epub 2018 Jan 10. Review.

PMID:
29322300
32.

The Effects of Subcutaneous Insulin Infusion Versus Multiple Insulin Injections on Glucose Variability in Young Adults with Type 1 Diabetes: The 2-Year Follow-Up of the Observational METRO Study.

Maiorino MI, Bellastella G, Casciano O, Cirillo P, Simeon V, Chiodini P, Petrizzo M, Gicchino M, Romano O, Caruso P, Giugliano D, Esposito K.

Diabetes Technol Ther. 2018 Feb;20(2):117-126. doi: 10.1089/dia.2017.0334. Epub 2018 Jan 5.

PMID:
29303370
33.

Intensive Lifestyle Intervention for Type 2 Diabetes.

Giugliano D, Maiorino MI, Esposito K.

JAMA. 2017 Dec 26;318(24):2494. doi: 10.1001/jama.2017.17232. No abstract available.

PMID:
29279921
34.

Diabetes is a cardiovascular disease, isn't it?

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

Diabetes Res Clin Pract. 2018 Jan;135:229-231. doi: 10.1016/j.diabres.2017.11.006. Epub 2017 Nov 14. No abstract available.

PMID:
29154911
35.

Changes in Diet Quality and Total and Cause-Specific Mortality.

Esposito K, Giugliano D, Maiorino MI.

N Engl J Med. 2017 Sep 28;377(13):1304. doi: 10.1056/NEJMc1710523. No abstract available.

PMID:
28976284
36.

Type 2 diabetes and cardiovascular prevention: the dogmas disputed.

Giugliano D, Maiorino MI, Bellastella G, Esposito K.

Endocrine. 2018 May;60(2):224-228. doi: 10.1007/s12020-017-1418-y. Epub 2017 Sep 11.

PMID:
28895030
37.

TSH oscillations in young patients with type 1 diabetes may be due to glycemic variability.

Bellastella G, Maiorino MI, Scappaticcio L, Casciano O, Petrizzo M, Caputo M, Paglionico VA, Giugliano D, Esposito K.

J Endocrinol Invest. 2018 Apr;41(4):389-393. doi: 10.1007/s40618-017-0752-5. Epub 2017 Aug 30.

PMID:
28856591
38.

Surgical approaches to adenocarcinoma of the gastroesophageal junction: the Siewert II conundrum.

Brown AM, Giugliano DN, Berger AC, Pucci MJ, Palazzo F.

Langenbecks Arch Surg. 2017 Dec;402(8):1153-1158. doi: 10.1007/s00423-017-1610-9. Epub 2017 Aug 12. Review.

PMID:
28803334
39.

Natural history of autoimmune primary ovarian insufficiency in patients with Addison's disease: from normal ovarian function to overt ovarian dysfunction.

De Bellis A, Bellastella G, Falorni A, Aitella E, Barrasso M, Maiorino MI, Bizzarro E, Bellastella A, Giugliano D, Esposito K; On the behalf of the Italian Addison Network.

Eur J Endocrinol. 2017 Oct;177(4):329-337. doi: 10.1530/EJE-17-0152. Epub 2017 Jul 21.

PMID:
28733292
40.

Comparative Quantitative Lymph Node Assessment in Localized Esophageal Cancer Patients After R0 Resection With and Without Neoadjuvant Chemoradiation Therapy.

Giugliano DN, Berger AC, Pucci MJ, Rosato EL, Evans NR, Meidl H, Lamb C, Levine D, Palazzo F.

J Gastrointest Surg. 2017 Sep;21(9):1377-1384. doi: 10.1007/s11605-017-3478-y. Epub 2017 Jun 29.

PMID:
28664255
41.

Particulate matter air pollution: individual choices for improving cardiometabolic well-being.

Esposito K, Bellastella G, Maiorino MI, Giugliano D.

Endocrine. 2018 Mar;59(3):495-498. doi: 10.1007/s12020-017-1326-1. Epub 2017 Jun 3.

PMID:
28578529
42.

Pituitary dysfunction in granulomatosis with polyangiitis.

Esposito D, Trimpou P, Giugliano D, Dehlin M, Ragnarsson O.

Pituitary. 2017 Oct;20(5):594-601. doi: 10.1007/s11102-017-0811-0. Review.

43.

Lifestyle recommendations for the prevention and management of metabolic syndrome: an international panel recommendation.

Pérez-Martínez P, Mikhailidis DP, Athyros VG, Bullo M, Couture P, Covas MI, de Koning L, Delgado-Lista J, Díaz-López A, Drevon CA, Estruch R, Esposito K, Fitó M, Garaulet M, Giugliano D, García-Ríos A, Katsiki N, Kolovou G, Lamarche B, Maiorino MI, Mena-Sánchez G, Muñoz-Garach A, Nikolic D, Ordovás JM, Pérez-Jiménez F, Rizzo M, Salas-Salvadó J, Schröder H, Tinahones FJ, de la Torre R, van Ommen B, Wopereis S, Ros E, López-Miranda J.

Nutr Rev. 2017 May 1;75(5):307-326. doi: 10.1093/nutrit/nux014.

44.

Genetics of medullary thyroid cancer: An overview.

Accardo G, Conzo G, Esposito D, Gambardella C, Mazzella M, Castaldo F, Di Donna C, Polistena A, Avenia N, Colantuoni V, Giugliano D, Pasquali D.

Int J Surg. 2017 May;41 Suppl 1:S2-S6. doi: 10.1016/j.ijsu.2017.02.064. Review.

45.

Surgical Apgar score (SAS) predicts perioperative morbidity, mortality, and length of stay in patients undergoing esophagectomy at a high-volume center.

Giugliano DN, Morgan A, Palazzo F, Leiby BE, Evans NR, Rosato EL, Berger AC.

J Surg Oncol. 2017 Sep;116(3):359-364. doi: 10.1002/jso.24662. Epub 2017 May 2.

PMID:
28464255
46.

Do intraoperative pyloric interventions predict the need for postoperative endoscopic interventions after minimally invasive esophagectomy?

Giugliano DN, Berger AC, Meidl H, Pucci MJ, Rosato EL, Keith SW, Evans NR, Palazzo F.

Dis Esophagus. 2017 Apr 1;30(4):1-8. doi: 10.1093/dote/dow034.

PMID:
28375478
47.

Insulin and Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Type 2 Diabetes: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Maiorino MI, Chiodini P, Bellastella G, Capuano A, Esposito K, Giugliano D.

Diabetes Care. 2017 Apr;40(4):614-624. doi: 10.2337/dc16-1957. Review.

PMID:
28325801
48.

Insights into the relationships between diabetes, prediabetes, and cancer.

Scappaticcio L, Maiorino MI, Bellastella G, Giugliano D, Esposito K.

Endocrine. 2017 May;56(2):231-239. doi: 10.1007/s12020-016-1216-y. Epub 2016 Dec 31. Review.

PMID:
28040833
49.

Efficacy and safety of insulin-GLP-1 receptor agonists combination in type 2 diabetes mellitus: a systematic review.

Cimmaruta D, Maiorino MI, Scavone C, Sportiello L, Rossi F, Giugliano D, Esposito K, Capuano A.

Expert Opin Drug Saf. 2016 Dec;15(sup2):77-83. Review.

PMID:
27875915
50.

Can diet prevent diabetes?

Maiorino MI, Bellastella G, Giugliano D, Esposito K.

J Diabetes Complications. 2017 Jan;31(1):288-290. doi: 10.1016/j.jdiacomp.2016.10.009. Epub 2016 Oct 17. No abstract available.

PMID:
27806882

Supplemental Content

Loading ...
Support Center